NIHR-Wellcome King's Clinical Research Facility

The NIHR-Wellcome King's Clinical Research Facility opened in November 2012. The building comprises of two main research areas within the Cheyne Wing of King's College Hospital, on the Denmark Hill campus of King's College London. The Clinical Research Facility spans three floors with a further standalone unit, the Clinical Trials Facility. Each area has been designed and built to compliment the other in terms of the ability to offer a unique and neutral space to carry out trials in a dedicated research setting.

We facilitate the work of established investigators, encourage and support the use of the facilities by new investigators and provide an environment in which the pharmaceutical industry will collaborate actively with our clinical investigators. We can accommodate all types of trials ranging from day and overnight studies to longer term stays.

The Cell Therapy Unit on the second floor is the largest manufacturing facility of its kind currently built in either academia or industry in Europe, with capacity to produce more than six final products simultaneously and a total of around a thousand therapies per year. This unit is financially supported through both the NHS and NIHR.  This is a sophisticated Good Manufacturing Practice (GMP) Unit built to the exacting standards required to meet the licensing requirements of the Medicines and Healthcare products Regulatory Agency (MHRA) for the manufacture of human cell and gene based therapies.

The Clinical Research Facility is academically supported by King’s Health Partners, a collaboration between King’s College London, South London and Maudsley NHS Foundation Trust, Guy’s and St Thomas’ NHS Foundation Trust, King's College Hospital NHS Foundation Trust.

The facility is funded directly through a National Institute of Health Research (NIHR) grant and indirectly through the NIHR Maudsley Biomedical Research Centre (BRC) for five years.